Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease

키워드

참고문헌 (38)

1. Kelly PJ, "Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study", Stroke, 39, pp.100~104 (2008)
2. Sánchez-Moreno C, "Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke", Stroke, 35, pp.163~168 (2004)
3. Leinonen JS, "Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke", Stroke, 31, pp.33~39 (2000)
4. Floyd RA, "Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases", Neurobiol Aging, 23, pp.795~807 (2002)
5. Tuñón J, "Mechanisms of action of statins in stroke", Expert Opin Ther Targets, 11, pp.273~278 (2007)
6. Amarenco P, "High-dose atorvastatin after stroke or transient ischemic attack", N Engl J Med, 355, pp.549~559 (2006)
7. Ridker PM, "Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein", N Engl J Med, 359, pp.2195~2207 (2008)
8. Adams RJ, "Update to the AHA", ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack, 2008, pp.39, 1647~1652
9. Bang OY, "Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke", J Neurol, 256, pp.591~599 (2009)
10. Hennerici MG, "Report of the 20th European Stroke Conference, Hamburg, May 24-27, 2011", Cerebrovasc Dis, 32, pp.589~613 (2011)
11. LaRosa JC, "Pleiotropic effects of statins and their clinical significance", Am J Cardiol, 88, pp.291~293 (2001)
12. Lima JA, "Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy", Circulation, 110, pp.2336~2341 (2004)
13. Ay H, "An evidence-based causative classification system for acute ischemic stroke", Ann Neurol, 58, pp.688~697 (2005)
14. Levine RL, "Carbonyl assays for determination of oxidatively modified proteins", Methods Enzymol, 233, pp.346~357 (1994)
15. Nagayama T, "Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia", J Neurochem, 75, pp.1716~1728 (2000)
16. Moon GJ, "Identification of oxidized serum albumin in the cerebrospinal fluid of ischaemic stroke patients", Eur J Neurol, 18, pp.1151~1158 (2011)
17. de Nigris F, "Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis", Trends Mol Med, 9, pp.351~359 (2003)
18. Corrêa Mde C, "Oxidative stress and erythrocyte acetylcholinesterase (AChE) in hypertensive and ischemic patients of both acute and chronic stages", Biomed Pharmacother, 62, pp.317~324 (2008)
19. Demirkaya S, "Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia", Eur J Neurol, 8, pp.43~51 (2001)
20. Polidori MC, "Plasma carotenoid and malondialdehyde levels in ischemic stroke patients:relationship to early outcome", Free Radic Res, 36, pp.265~268 (2002)
21. Alexandrova ML, "stress in the chronic phase after stroke", Redox Rep, 8, pp.169~176 (2003)
22. Ishigaki Y, "Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis", Circulation, 118, pp.75~83 (2008)
23. Gil-Núñez AC, "Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors", Cerebrovasc Dis, 11(Suppl 1), pp.85~95 (2001)
24. Uno M, "Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement", Neurol Res, 27, pp.94~102 (2005)
25. Ky B, "The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans", J Am Coll Cardiol, 51, pp.1653~1662 (2008)
26. Mason RP, "Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress", Circulation, 109(21 Suppl 1), pp.II34~II41 (2004)
27. Skrha J, "Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes", Eur J Pharmacol, 493, pp.183~189 (2004)
28. Molcányiová A, "Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia", Pharmacol Res, 54, pp.203~207 (2006)
29. Burcham PC, "Introduction of carbonyl groups into proteins by the lipid peroxidation product, malondialdehyde", Biochem Biophys Res Commun, 220, pp.996~1001 (1996)
30. Chang CY, "Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan", Free Radic Res, 28, pp.15~24 (1998)
31. Liu H, "Peripheral oxidative biomarkers constitute a valuable indicator of the severity of oxidative brain damage in acute cerebral infarction", Brain Res, 1025, pp.43~50 (2004)
32. Li S, "Increased oxidative protein and DNA damage but decreased stress response in the aged brain following experimental stroke", Neurobiol Dis, 18, pp.432~440 (2005)
33. Aydin S, "Effects of atorvastatin therapy on protein oxidation and oxidative DNA damage in hypercholesterolemic rabbits", Pharmacol Res, 59, pp.242~247 (2009)
34. Blakeman DP, "Protein oxidation: examination of potential lipid-independent mechanisms for protein carbonyl formation", J Biochem Mol Toxicol, 12, pp.185~190 (1998)
35. Cano CP, "Increased serum malondialdehyde and decreased nitric oxide within 24 hours of thrombotic stroke onset", Am J Ther, 10, pp.473~476 (2003)
36. Zimmermann C, "Antioxidant status in acute stroke patients and patients at stroke risk", Eur Neurol, 51, pp.157~161 (2004)
37. Steinberg D, "Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity", N Engl J Med, 320, pp.915~924 (1989)
38. Rosenson RS, "Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities", Atherosclerosis, 173, pp.1~12 (2004)

관련 논문AI추천